Ignite Creation Date:
2024-05-06 @ 1:14 PM
Last Modification Date:
2024-10-26 @ 1:11 PM
Study NCT ID:
NCT03966729
Status:
UNKNOWN
Last Update Posted:
2022-07-07
First Post:
2019-02-04
Brief Title:
Relationships and Differences Analysis in Heart Failure
Sponsor:
Wuerzburg University Hospital
Organization:
Wuerzburg University Hospital
Study Overview
Official Title:
Retrospektive Datenanalyse Von Herzinsuffizienzpatienten in Der Kardiologie Des Universitätsklinikums Würzburg
Status:
UNKNOWN
Status Verified Date:
2022-07
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
REDEAL-HF
Brief Summary:
This study characterizes heart failure patients who attended the University Hospital Würzburg The primary aim is a better understanding of the relationships and differences between the subgroups HFrEF EF 40 HFmrEF EF 40-49 and HFpEF EF50 contributing to an improved diagnosis prognosis and therapy of patients with heart failure
Detailed Description:
The varying clinical picture of heart failure HF represents a major challenge for patient care in Germany HF is one of the most common reasons for hospitalization in the Western world In the chronic course of heart failure affected patients are committed to morbidity lifelong therapy and high risk of cardiac decompensation also associated with high mortality
Heart failure patients who visited the Cardiology Department of the University Hospital Wuerzburg shall be analyzed with regard to all clinical data and outcome This retrospective work should help to better understand the three groups HFrEF EF 40 HFmrEF EF 40-49 and HFpEF EF50 and help identifying similarities and differences between the groups
Hereby we hope for progress in diagnostic prognostic and therapeutic aspects of heart failure
Heart failure patients who visited the Cardiology Department of the University Hospital Wuerzburg shall be analyzed with regard to all clinical data and outcome This retrospective work should help to better understand the three groups HFrEF EF 40 HFmrEF EF 40-49 and HFpEF EF50 and help identifying similarities and differences between the groups
Hereby we hope for progress in diagnostic prognostic and therapeutic aspects of heart failure
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None